Zenlabs Ethica Ltd

On 02-Dec, Zenlabs Ethica Ltd witnessed a significant decline in its share price, closing at ₹26.99, down ₹1.53 or 5.36% from the previous session. This drop continues a sustained downward trajectory for the stock, reflecting broader challenges faced by the company’s shares over recent periods.

As of 10-Nov, Zenlabs Ethica Ltd's stock price is Rs 29.87, down 6.19%, with a total decline of 6.66% over the last two days. The stock is underperforming compared to the Sensex, showing significant volatility and decreased investor participation.

Zenlabs Ethica has experienced a decline in net sales and profits from Mar'22 to Mar'25, with net sales dropping from 69.09 Cr to 51.42 Cr and profit after tax decreasing from 1.26 Cr to 0.27 Cr. However, cash flow from operations improved significantly, rising to 3.00 Cr in Mar'25 from a negative 9.00 Cr in Mar'24.

Zenlabs Ethica's latest Q2 FY26 results show an 8.28% revenue increase to ₹12.43 crores, but net profit fell 20% to ₹0.04 crores, indicating significant challenges with profitability and operational efficiency. Overall, while there is some revenue growth, the company faces serious issues with margin erosion and declining returns.

As of 04-Nov, Zenlabs Ethica Ltd's stock price is Rs 32.20, up 5.02% today, with a three-day gain of 8.97%. Despite recent short-term outperformance against the Sensex, the stock has declined 18.48% year-to-date.

As of 29-Oct, Zenlabs Ethica Ltd is priced at 29.85, showing a short-term increase but a significant year-to-date decline of 24.43%. The stock is underperforming compared to the Sensex and has seen a notable drop in investor interest, indicating a bearish trend despite today's slight uptick.

As of 24-Oct, Zenlabs Ethica Ltd's stock price is Rs 28.35, down 9.54%, and has dropped 12.2% over the last two days. The stock is near its 52-week low and has significantly underperformed the market, with a year-to-date decline of 28.23% and reduced investor participation.

As of 20-October, Zenlabs Ethica Ltd's stock price is rising to Rs 31.85, up 6.81% today after reversing a two-day decline. Despite a challenging year with a 19.37% year-to-date drop, the stock shows short-term recovery and increased investor participation.

As of 17-Oct, Zenlabs Ethica Ltd's stock price rose to Rs 31.70, a 3.7% increase, but it remains below key moving averages and has shown negative performance over the past month and year. Despite today's gains, the stock's long-term outlook is weak compared to the broader market.

As of 01-October, Zenlabs Ethica Ltd's stock price is Rs 31.45, up 6.5% today, but it has underperformed over the past week, month, and year. Despite a short-term gain, the stock lags behind the Sensex and faces challenges in regaining investor confidence.

As of 30-Sep, Zenlabs Ethica Ltd's stock price is at 30.45, down 2.9%, and has significantly underperformed its sector and the broader market. Year-to-date, it has declined by 22.91%, contrasting sharply with the Sensex's increase of 2.72%.

As of 18-Sep, Zenlabs Ethica Ltd's stock price is declining at 31.25, down 2.34%, and underperforming its sector. The stock is trading below all key moving averages and has seen significant negative returns over various periods, indicating weak investor sentiment and ongoing challenges.

As of 18-Aug, Zenlabs Ethica Ltd's stock price is declining at 31.11, down 2.72%, and has underperformed its sector significantly. Weak fundamentals, negative growth in net sales, and low investor interest contribute to its bearish trend and substantial year-to-date decline of 21.24%.

As of 12-Aug, Zenlabs Ethica Ltd's stock price is at 31.13, down 1.8%, and has underperformed its sector. The stock has declined 21.19% year-to-date, reflecting weak fundamentals and negative growth in net sales.

Zenlabs Ethica, a microcap in the diversified commercial services sector, reported disappointing financial results for the quarter ending June 2025, with net sales and profit metrics at their lowest. The company's stock has declined over various periods, reflecting ongoing challenges in maintaining market competitiveness.

Zenlabs Ethica has experienced a declining trend in net sales and profits from Mar'22 to Mar'25, with net sales dropping from 69.09 Cr to 51.42 Cr and profit after tax falling from 0.82 Cr to 0.27 Cr, indicating operational and market challenges. Additionally, cash flow from operating activities was negative at -9.00 Cr in Mar'24.

Zenlabs Ethica's latest results are concerning, showing a 10.7% decline in net sales to Rs 11.48 crore, the lowest in five quarters, along with reduced operating profit and earnings per share, indicating challenges in profitability and operational effectiveness.